186 related articles for article (PubMed ID: 36159526)
1. Gallbladder neuroendocrine carcinoma diagnosis, treatment and prognosis based on the SEER database: A literature review.
Cai XC; Wu SD
World J Clin Cases; 2022 Aug; 10(23):8212-8223. PubMed ID: 36159526
[TBL] [Abstract][Full Text] [Related]
2. Clinical Analysis of 15 Cases of Gallbladder Neuroendocrine Carcinoma and Comparison with Gallbladder Adenocarcinoma Using a Propensity Score Matching.
Yan S; Wang Y; Chen X; Zhang Y; Huang Z; Zhao J; Zhou J; Li Z; Bi X; Luo Z; Cai J; Zhao H
Cancer Manag Res; 2020; 12():1437-1446. PubMed ID: 32161496
[TBL] [Abstract][Full Text] [Related]
3. Update in clinical management for gallbladder neuroendocrine carcinoma.
Chu H; Shi Y; Liu J; Huang D; Zhang J; Dou C
Medicine (Baltimore); 2021 Apr; 100(14):e25449. PubMed ID: 33832150
[TBL] [Abstract][Full Text] [Related]
4. Clinical features and outcomes analysis of Gallbladder neuroendocrine carcinoma.
Jiang M; Zhang Y
J Cancer Res Ther; 2023 Aug; 19(4):910-916. PubMed ID: 37675716
[TBL] [Abstract][Full Text] [Related]
5. Gallbladder neuroendocrine carcinoma: report of 10 cases and comparision of clinicopathologic features with gallbladder adenocarcinoma.
Chen C; Wang L; Liu X; Zhang G; Zhao Y; Geng Z
Int J Clin Exp Pathol; 2015; 8(7):8218-26. PubMed ID: 26339390
[TBL] [Abstract][Full Text] [Related]
6. Clinical outcomes of small cell neuroendocrine carcinoma and adenocarcinoma of the gallbladder.
Yun SP; Shin N; Seo HI
World J Gastroenterol; 2015 Jan; 21(1):269-75. PubMed ID: 25574101
[TBL] [Abstract][Full Text] [Related]
7. Neuroendocrine neoplasms of the gallbladder: early detection and surgery is key to improved outcome.
Gogna S; Samson D; Gachabayov M; Rojas A; Felsenreich DM; Koo D; Gu K; Quintero L; Miller KR; Azim A; Da Eric Dong X
Langenbecks Arch Surg; 2022 Feb; 407(1):197-206. PubMed ID: 34236488
[TBL] [Abstract][Full Text] [Related]
8. Comparison of the Clinical Features and Outcomes of Gallbladder Neuroendocrine Carcinoma with Those of Adenocarcinoma: A Propensity Score-Matched Analysis.
Do MY; Jang SI; Kang HP; Kim EJ; Lee KJ; Park GE; Lee SJ; Lee DK; Woo SM; Cho JH
Cancers (Basel); 2021 Sep; 13(18):. PubMed ID: 34572940
[TBL] [Abstract][Full Text] [Related]
9. Gallbladder neuroendocrine carcinoma: A report of two cases and literature review.
Liao Y; Cao W; Li Z; Xu X; Zhang Y; Liu Z; Miao J; Zhou Y; Zhen Z; Liu D; Li H; Chai L; Wei Y; Zhang X; Zhang L; Wang J; Tian Y
Oncol Lett; 2023 Jun; 25(6):229. PubMed ID: 37153064
[TBL] [Abstract][Full Text] [Related]
10. Comparative prognosis and risk assessment in gallbladder neuroendocrine neoplasms versus adenocarcinomas.
Zhao ZH; Huang Y; Jiang C; Lv GY; Wang M
Front Endocrinol (Lausanne); 2024; 15():1326112. PubMed ID: 38390209
[TBL] [Abstract][Full Text] [Related]
11. Neuroendocrine Carcinoma of Gall Bladder: A Series of 19 Cases with Review of Literature.
Kamboj M; Gandhi JS; Gupta G; Sharma A; Pasricha S; Mehta A; Chandragouda D; Sinha R
J Gastrointest Cancer; 2015 Dec; 46(4):356-64. PubMed ID: 26208508
[TBL] [Abstract][Full Text] [Related]
12. Age-specific clinicopathological characteristics and prognostic analysis of neuroendocrine carcinomas of the gallbladder.
Zhang Z; Guo T; Huang X; Xie P; Wang L; Yu Y
Cancer Med; 2022 Feb; 11(3):641-653. PubMed ID: 34841738
[TBL] [Abstract][Full Text] [Related]
13. Clinicopathological features and survival for gallbladder NEN: a population-based study.
Cen D; Liu H; Wan Z; Lin Z; Wang Y; Xu J; Liang Y
Endocr Connect; 2019 Sep; 8(9):1273-1281. PubMed ID: 31398710
[TBL] [Abstract][Full Text] [Related]
14. Clinicopathological characteristics and prognostic factors of patients with primary gallbladder neuroendocrine carcinomas.
Wang W; Yang CX; Yu XZ; Zhang SL; Wang J; Wang J
J Dig Dis; 2022 Mar; 23(3):166-173. PubMed ID: 35187836
[TBL] [Abstract][Full Text] [Related]
15. Neuroendocrine Neoplasms of the Gallbladder: A Clinicopathological Analysis of 13 Patients and a Review of the Literature.
Wang P; Chen J; Jiang Y; Jia C; Pang J; Wang S; Chang X
Gastroenterol Res Pract; 2021; 2021():5592525. PubMed ID: 34122537
[TBL] [Abstract][Full Text] [Related]
16. Can surgical treatment be justified for neuroendocrine carcinoma of the gallbladder?
You YH; Choi DW; Heo JS; Han IW; Choi SH; Jang KT; Han S
Medicine (Baltimore); 2019 Mar; 98(11):e14886. PubMed ID: 30882701
[TBL] [Abstract][Full Text] [Related]
17. Poorer prognosis for neuroendocrine carcinoma than signet ring cell cancer of the colon and rectum (CRC-NEC): a propensity score matching analysis of patients from the Surveillance, Epidemiology, and End Results (SEER) database.
Chen Y; Tu J; Zhou S; Fu J; Wang Q
Int J Colorectal Dis; 2021 Apr; 36(4):745-756. PubMed ID: 33415449
[TBL] [Abstract][Full Text] [Related]
18. Differential and prognostic MRI features of gallbladder neuroendocrine tumors and adenocarcinomas.
Bae JS; Kim SH; Yoo J; Kim H; Han JK
Eur Radiol; 2020 May; 30(5):2890-2901. PubMed ID: 32025835
[TBL] [Abstract][Full Text] [Related]
19. Prognosis and Treatment Outcomes of Bone Metastasis in Gallbladder Adenocarcinoma: A SEER-Based Study.
Gera K; Kahramangil D; Fenton GA; Martir D; Rodriguez DN; Ijaz Z; Lin RY; Rogers SC; Ramnaraign BH; George TJ; Hong YR; Hughes SJ; Nassour I; Sahin I
Cancers (Basel); 2023 Oct; 15(20):. PubMed ID: 37894422
[TBL] [Abstract][Full Text] [Related]
20. Complete remission of gallbladder neuroendocrine carcinoma with liver metastasis by tislelizumab plus chemotherapy: a case report.
Li H; Qiao J; Kou X; Wu C; Liu H; Qiu J
Front Oncol; 2024; 14():1346290. PubMed ID: 38357198
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
